Combining stretching and gallic acid to decrease inflammation indices and promote extracellular matrix production in osteoarthritic human articular chondrocytes

Exp Cell Res. 2021 Nov 15;408(2):112841. doi: 10.1016/j.yexcr.2021.112841. Epub 2021 Sep 24.

Abstract

Osteoarthritis (OA) patients undergo cartilage degradation and experience painful joint swelling. OA symptoms are caused by inflammatory molecules and the upregulation of catabolic genes leading to the breakdown of cartilage extracellular matrix (ECM). Here, we investigate the effects of gallic acid (GA) and mechanical stretching on the expression of anabolic and catabolic genes and restoring ECM production by osteoarthritic human articular chondrocytes (hAChs) cultured in monolayers. hAChs were seeded onto conventional plates or silicone chambers with or without 100 μM GA. A 5% cyclic tensile strain (CTS) was applied to the silicone chambers and the deposition of collagen and glycosaminoglycan, and gene expressions of collagen types II (COL2A1), XI (COL11A2), I (COL1A1), and X (COL10A1), and matrix metalloproteinases (MMP-1 and MMP-13) as inflammation markers, were quantified. CTS and GA acted synergistically to promote the deposition of collagen and glycosaminoglycan in the ECM by 14- and 7-fold, respectively. Furthermore, the synergistic stimuli selectively upregulated the expression of cartilage-specific proteins, COL11A2 by 7-fold, and COL2A1 by 47-fold, and, in contrast, downregulated the expression of MMP-1 by 2.5-fold and MMP-13 by 125-fold. GA supplementation with CTS is a promising approach for restoring osteoarthritic hAChs ECM production ability making them suitable for complex tissue engineering applications.

Keywords: And inflammation; Articular cartilage tissue engineering; Chondrocytes; Collagen; Cyclic tensile stress; Gallic acid; Glycosaminoglycan.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Cartilage, Articular / drug effects*
  • Cells, Cultured
  • Chondrocytes / drug effects
  • Chondrocytes / metabolism
  • Chondrocytes / pathology
  • Collagen Type I, alpha 1 Chain / genetics
  • Collagen Type II / genetics
  • Collagen Type X / genetics
  • Collagen Type XI / genetics
  • Extracellular Matrix / drug effects
  • Extracellular Matrix / genetics*
  • Gallic Acid / pharmacology
  • Gene Expression Regulation / drug effects
  • Humans
  • Inflammation / genetics
  • Inflammation / pathology
  • Inflammation / therapy*
  • Matrix Metalloproteinase 1 / genetics
  • Matrix Metalloproteinase 13 / genetics
  • Muscle Stretching Exercises*
  • Osteoarthritis / genetics
  • Osteoarthritis / pathology
  • Osteoarthritis / therapy*

Substances

  • COL10A1 protein, human
  • COL11A2 protein, human
  • COL2A1 protein, human
  • Collagen Type I, alpha 1 Chain
  • Collagen Type II
  • Collagen Type X
  • Collagen Type XI
  • Gallic Acid
  • MMP13 protein, human
  • Matrix Metalloproteinase 13
  • MMP1 protein, human
  • Matrix Metalloproteinase 1